Edwards Lifesciences Profile

<div class='circular--portrait' style='background:#CD0D74;color: white;font-size:4em;padding-top: 15px;;'>EW</div>


7 / 100

Odds of Distress

Analyze Filter   Earning Report: January 30, 2020
Equity ratings for Edwards Lifesciences Corporatio are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting October 22, 2019 and ending today January 20, 2020. Click here to learn more.

Edwards Lifesciences Profile

Upcoming quarterly earning report is expected on January 30, 2020. Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States and internationally. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 12800 people. more on Edwards Lifesciences
Edwards Lifesciences Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
Edwards Lifesciences SEC Filings
Edwards Lifesciences SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameEdwards Lifesciences Corporatio
ChairmanMichael MussallemView All
Thematic Classifications
Active investing themes Edwards Lifesciences currently participates. An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
showing 2 out of 3 themes  View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Edwards Lifesciences.
Piotroski F Score
Academic score to determine the current strength of Edwards Lifesciences financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Financial Strength
Edwards Lifesciences ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Long Term Debt to Equity
Debt to Equity Ratio
Return on Investment
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Average Bond Rating: BBB-Tolerable
Few selected profitability drivers of Edwards Lifesciences representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
Net Income Per Employee
Operating Margin
Gross Margin
Profit Margin
Edwards Lifesciences Corporatio (EW) is traded on BATS Exchange in USA. It is located in One Edwards Way, Irvine, CA 92614, United States and employs 12,800 people. Edwards Lifesciences is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with market capitalization of 44.74 B. Edwards Lifesciences is active under Healthcare sector as part of Medical Devices industry. The entity has 207.97 M outstanding shares of which 2.35 M shares are currently sold short in the market by investors with about 1.76 days to cover all shorted shares. EDWARDS LIFESCIEN reports about 934.3 M in cash with 540.15 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.49.
Check Edwards Lifesciences Probability Of Bankruptcy

Ownership Allocation (%)

Edwards Lifesciences Target Price Odds Analysis

Odds Below 238.64HorizonTargetOdds Above 238.64
67.46%30 days 238.64 32.13%
Based on normal probability distribution, the odds of Edwards Lifesciences to move above current price in 30 days from now is about 32.13 (This Edwards Lifesciences Corporatio probability density function shows the probability of Edwards Lifesciences Stock to fall within a particular range of prices over 30 days) .

Edwards Lifesciences Top Holders

Edwards Lifesciences Corporatio Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Edwards Lifesciences Against Markets

Did you try this?

Run Idea Analyzer Now


Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module

Edwards Lifesciences Upcoming and Recent Events

Edwards Lifesciences Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportJanuary 30, 2020
Next Earnings ReportApril 28, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndJanuary 30, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Edwards Lifesciences Corporate Filings

Edwards Lifesciences SEC Reporting

Financial Statements and Exhibits. Results of Operations and Financial Condition
Other Events. Submission of Matters to a Vote of Security Holders
Unclassified Corporate Event

Edwards Lifesciences Corporate Directors

John Cardis Independent Director
Wesley Schack Presiding Independent Director
Nicholas Valeriani Independent Director
Continue to Investing Opportunities. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Company logos by clearbit